Green Tea Extract (GTE) improves differentiation in human osteoblasts during oxidative stress

Journal of Inflammation (Impact Factor: 2.02). 05/2014; 11(1):15. DOI: 10.1186/1476-9255-11-15
Source: PubMed


Oxidative stress is involved in the pathogenesis of bone diseases such as osteoporosis, which has a high coincidence with fractures in elderly. Several studies showed positive effects of herbal bioactive substances on oxidative stress. This study analyses the effect of green tea extract (GTE) Sunphenon 90LB on primary human osteoblasts differentiation and viability during H2O2-induced oxidative stress. Moreover, it was analyzed, whether GTE acts during the HO-1 signaling pathway.

Human osteoblasts were isolated from femoral heads of patients undergoing total hip replacement. Beneficial effects of GTE on osteoblasts were examined in a dose- and time-dependent manner. Furthermore, GTE was given before, simultaneous with and after induction of oxidative stress with 1 mM H2O2 to simulate prophylactic, acute and therapeutic use, respectively. Cell damage was measured by LDH leakage and cell viability by MTT assay. Flow cytometry was applied to measure formation of Reactive Oxygen Species by using 2`7`-dichlorofluorescein-diacetate. The formation of Extracellular Matrix after differentiation with GTE supplementation during oxidative stress was visualized with von Kossa and Alizarin Red staining. Last one was additionally photometrically quantified. To assess the effects of H2O2 and GTE on the osteogenic genes, RT-PCR was performed. To evaluate the intramolecular influence of GTE after the stimulation the protein levels of HO-1 were analyzed.

Stimulation of primary human osteoblasts with low doses of GTE during oxidative stress over 21 days improved mineralization. Furthermore, GTE supplementation in combination with H2O2 leads to a higher gene expression of osteocalcin and collagen1α1 during osteoblasts differentiation. Both are important for bone quality. Pre-incubation, co-incubation and post-incubation of osteoblasts with high doses of GTE protect the osteoblasts against acute oxidative stress as shown by increased cell viability, decreased LDH leakage, and reduced production of intracellular free radicals. Functional analysis revealed an increased HO-1 protein synthesis after stimulation with GTE.

Incubation of human primary osteoblasts with GTE significantly reduces oxidative stress and improves cell viability. GTE also has a beneficial effect on ECM production which might improve the bone quality. Our findings suggest that dietary supplementation of GTE might reduce inflammatory events in bone-associated diseases such as osteoporosis.

Download full-text


Available from: Claudine Seeliger, Aug 25, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Green tea consumption has a long tradition in Asian countries - especially China. The epidemiologically and experimentally observed anticarcinogenic and antiinflammatory effects of green tea have led to the implementation of green tea extracts in multiple therapeutic applications - both in dermatological and cosmeceutical preparations. The most abundant evidence exists for the anticarcinogenic and chemopreventive effect of green tea or its major constituent epigallocatechin-3-gallate. Almost equally evident is the effect in infectious diseases such as cutaneous viral infections. For external genital warts, a topical ointment with green tea extracts was licensed in the USA in 2010, and recently also in Europe. Experimental evidence pinpointing the block of central signal transduction factors in inflammatory mechanisms has led to the evaluation of catechins in inflammatory disorders such as atopic dermatitis. The belief of green tea as a "wonder weapon" against diseases dates back thousands of years. According to a Chinese legend, ancient Emperor Shen Nung noted a delightful aroma after some leaves of a nearby tree had fallen into boiling water. He immediately proclaimed the new "drink" as "heaven-sent", starting the belief - persisting until today - of green tea as a medication from nature against many different diseases. This review summarizes biological effects and clinical implications of green tea. © 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
    Journal der Deutschen Dermatologischen Gesellschaft 07/2015; 13(8). DOI:10.1111/ddg.12737 · 2.05 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Der Genuss von grünem Tee hat in asiatischen Ländern - vor allem in China - eine lange Tradition. Die epidemiologisch und experimentell beobachteten antikarzinogenen und antiinflammatorischen Effekte von grünem Tee haben zum Einsatz von Grüntee-Extrakten bei verschiedenen therapeutischen Anwendungen geführt - sowohl in dermatologischen als auch in kosmetischen Präparaten, wobei die umfangreichsten Untersuchungen für die antikarzinogene und chemopräventive Wirkung von grünem Tee bzw. seines Hauptbestandteils Epigallocatechin-3-gallat vorliegen. Fast ebenso gut nachgewiesen ist die Wirkung bei Infektionskrankheiten wie kutanen Virusinfektionen. Zur topischen Behandlung von Genitalwarzen wurde eine Salbe mit Grüntee-Extrakten 2010 in den USA und kürzlich auch in Europa zugelassen. Experimentelle Daten, die auf eine Blockade zentraler Signaltransduktionsfaktoren hinweisen, haben zur Untersuchung von Catechinen bei entzündlichen Erkrankungen wie atopischer Dermatitis geführt. Die Ansicht, grüner Tee sei eine "Wunderwaffe" gegen Krankheiten, ist bereits Tausende von Jahren alt. Einer chinesischen Legende zufolge bemerkte der antike Kaiser Shen Nung ein herrliches Aroma, nachdem einige Blätter eines in der Nähe stehenden Baumes in kochendes Wasser gefallen waren. Sofort erklärte er das neue "Getränk" zu einem "Geschenk des Himmels", was den Ursprung der - bis heute bestehenden - Überzeugung bildete, grüner Tee sei ein Arzneimittel aus der Natur und gegen viele verschiedene Krankheiten wirksam. Dieser Übersichtsartikel fasst die biologischen und klinischen Effekte von grünem Tee zusammen. © 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
    Journal der Deutschen Dermatologischen Gesellschaft 08/2015; 13(8):768-776. DOI:10.1111/ddg.20_12737 · 2.05 Impact Factor